Newsbot

Should Value Investors Buy Tutor Perini (TPC) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are Investors Undervaluing Heritage Insurance (HRTG) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Is John B. Sanfilippo & Son (JBSS) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Morgan Stanleys Wilson Bullish on Stocks for 2026

Morgan Stanley strategist Michael Wilson is bullish on stocks for next year and sees the S&P 500 finishing at 7,800. Wilson says the Federal Reserve needs to cut rates and he talks about the rally in AI stocks. He speaks on "Bloomberg Surveillance." (Source: Bloomberg)

Das beste Restaurant der Welt: Schwarzwaldstube erneut auf Platz 1 bei La Liste 2026

Die „Schwarzwaldstube“ behauptet sich an der Weltspitze der Haute Cuisine: Im aktuellen Meta-Ranking von La Liste, dem internationalen „Guide der Guides“, schafft es das Restaurant in der Baiersbronner Traube Tonbach zum dritten Mal in Folge auf Platz 1 weltweit.BAIERSBRONN / PARIS, 24. November 2025 – Die „Schwarzwaldstube“ im Traditionshotel Traube Tonbach ist erneut als bestes Restaurant der Welt ausgezeichnet worden. In der soeben von La Liste in Paris veröffentlichten Weltrangliste für 202...

London: Schärfere Kontrolle der Einreisegenehmigung

Die britische Regierung hat verschärfte Kontrollen der Einreisegenehmigung ETA angekündigt. Die "Electronic Travel Authorisation" ist bei Reisen ins Vereinigte Königreich bereits seit April Pflicht für alle deutschen Reisenden, die kein Visum haben. Kontrolliert wird bislang aber nur selten. Vom 25. Februar 2026 an werde das System strikt umgesetzt, teilte London mit. Die ETA ist mit dem Reisepass...

Disneyland quietly pulls the plug on a popular service

Walt Disney once said, “Disneyland will never be completed as long as there is imagination left in the world.” His words remain true, as Disneyland continues to evolve with the times.  Disneys Experiences division remains successful, drawing millions of guests to parks each year, according to ...

Wall Street Analysts Think Grab (GRAB) Is a Good Investment: Is It?

According to the average brokerage recommendation (ABR), one should invest in Grab (GRAB). It is debatable whether this highly sought-after metric is effective because Wall Street analysts recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Wall Street Analysts Think Cameco (CCJ) Is a Good Investment: Is It?

Based on the average brokerage recommendation (ABR), Cameco (CCJ) should be added to ones portfolio. Wall Street analysts overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

Wall Street Analysts See Bit Digital (BTBT) as a Buy: Should You Invest?

According to the average brokerage recommendation (ABR), one should invest in Bit Digital (BTBT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Junge Menschen aus aller Welt sind eingeladen, sich für das Doha Debates Ambassador-Programm zu bewerben

DOHA, Katar--(BUSINESS WIRE)--Die Qatar Foundation lädt im Rahmen von Doha Debates junge Menschen im Alter von 18 bis 26 Jahren aus aller Welt dazu ein, sich für die achte Auflage ihres internationalen Ambassador-Programms zu bewerben. Dieses virtuelle 12-Wochen-Programm bietet den Teilnehmern die Möglichkeit, sich an konstruktiven Dialogen zu beteiligen, Lösungen für globale Herausforderungen zu erarbeiten und dauerhafte Beziehungen zu anderen aufstrebenden Persönlichkeiten aufzubauen. Die Bew

Time for Non-AI Companies to ‘Show Off,’ Says Ed Yardeni

“I think you could have a situation where the magnificent seven become a little less valuable and the rest of the market becomes more valuable,” says Ed Yardeni, founder and chief investment strategist at Yardeni Research. He expects the earnings for non-AI companies in the S&P 500 “to really shine.” (Source: Bloomberg)

Energiekontor Aktie steigt 2,5%: Hedgefonds Acadian stockt Short-Quote auf - kommt der große Knall?

Bad Marienberg (www.aktiencheck.de) - ? Energiekontor-Aktie: Acadian Asset Management erhöht Short-Position – Hedgefonds wittern SchwächeDie Energiekontor-Aktie gerät immer stärker ins Visier internationaler Hedgefonds. Am 21. November 2025 meldete Acadian Asset Management LLC eine deutliche Erhöhung ihrer Netto-Leerverkaufsposition – von 1,03% auf 1,10%. [mehr]

RVPH: Brilaroxazine Poster Presentations

By John Vandermosten, CFANASDAQ:RVPHREAD THE FULL RVPH RESEARCH REPORTReviva Pharmaceutical Holdings, Inc. (NASDAQ:RVPH) reported 3Q:25 results, confirming the pre-new drug application (NDA) meeting with the FDA in 4Q:25 to see if an NDA can be accepted using existing data. It reiterated the possibility of an NDA submission to the FDA in 2Q:26 if the agency indicates the application is acceptable with existing data. Success in this endeavor would be a material positive and would provide a fa...

Health insurers rise on report Trump considering ACA subsidy extension

Shares of U.S. health insurers jumped on Monday following media reports the White House was preparing to unveil a health policy framework that would extend Affordable Care Act premium subsidies - also known as Obamacare - for two years and add new eligibility limits.

dpa-AFX-Überblick: UNTERNEHMEN vom 24.11.2025 - 15.15 UHr

ROUNDUP: Gerinnungshemmer Asundexian doch wieder Hoffnungsträger für Bayer LEVERKUSEN/BERLIN - Zwei Jahre nach einem schweren Rückschlag mit dem Pharma-Wirkstoff Asundexian hat Bayer mit dem Blutgerinnungshemmer nun einen wichtigen Erfolg in der S...